Navigation Links
Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
Date:2/19/2008

pment. In addition to the over 56 ErbB-targeted agents in development (35 in current clinical trials), numerous molecular markers/pathways are being recognized as contributing to the success or failure of the ErbB pathway inhibitors. A series of reports (http://www.newmedinc.com/futonc/sample.pdf) on currently approved therapeutics as well as those in development targeting the ErbB pathway, including EGFr and HEr2 inhibitors, published by Future Oncology (http://www.newmedinc.com), highlights the contribution of molecular profiling in the characterization of cancer and its treatment.

New Medicine's Oncology KnowledgeBASE (nm|OK) is a Complete Knowledge Environment in Drug Development in Cancer

Unlike standard drug databases, nm|OK residing at http://www.nmok.net, is designed to specifically provide a fully realized environment reflecting every aspect of drug development in oncology. nm|OK is an edited, inclusive analysis of all aspects of oncology drug development worldwide, including technologies, targets, companies, business affiliations, medical and clinical developments, protocols and results of thousands of clinical trials, and global markets, among others. Currently, nm|OK profiles over 2,000 anticancer agents/technologies in current development (over 4,000 drugs overall) or on the market, more than 1,200 targets implicated in malignancy, and more than 2,000 companies developing/marketing products in the oncology sector. Protocols, interim and final results are presented for thousands of trials, searchable by both novel and approved agents in monotherapy or combination therapy regiments. In addition, nm|OK describes hundreds of diagnostic, prognostic, and theragnostic methodologies and products as they relate to treatment candidate selection, evaluation of the results of clinic
'/>"/>

SOURCE New Medicine, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
2. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
3. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
4. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
5. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
10. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
11. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... WASHINGTON , May 21, 2015 ... following statement regarding the Medicare Part D offsets ... Century Cures initiative: "If the 21st Century ... billions from America,s premier health program – Medicare ... it may yield down the road. ...
(Date:5/21/2015)... May 21, 2015 ... - Zwecks Leistungsvergleich zur Expertise und ... EG-Mitgliedstaaten verwiesen, in denen uneingeschränkt betriebsfähige ... Sie ein Aegate-Land: beispielsweise BELGIEN   ... Bekämpfung von Arzneimittelfälschungen (FMD) handelt es ...
(Date:5/21/2015)... In praising today,s unanimous passage of ... House Energy and Commerce Committee, the Senior Care ... the unique challenges facing long-term care (LTC) pharmacy ... exempting Part D beneficiaries in skilled nursing facilities ... "lock-in" provision. The SCPC has made the case ...
Breaking Medicine Technology:EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3SCPC Applauds Unanimous House Panel Passage of 21st Century Cures Bill Recognizing Unique Challenges Facing Long Term Care (LTC) Pharmacy Patients, Providers 2
... 2, 2007-The U.S. Food and Drug,Administration (FDA) today ... existing black box warning on,their products' labeling to ... behavior, known as suicidality, in young,adults ages 18 ... to two months). , The proposed labeling changes ...
... FDA notified,healthcare professionals of important new safety ... recent,clinical study in patients with limited-stage small ... phase,II clinical trial study combined chemotherapy and ... serious adverse events of TE,fistula (one fatal) ...
Cached Medicine Technology:FDA Proposes New Warnings About Suicidal Thinking, Behavior in,Young Adults Who Take Antidepressant Medications 2FDA Proposes New Warnings About Suicidal Thinking, Behavior in,Young Adults Who Take Antidepressant Medications 3
(Date:5/23/2015)... (PRWEB) May 23, 2015 A live auction ... equipment from hospitals, surgery centers and other medical facilities around ... sold including endoscopy, lab, radiology, surgery, anesthesia, exam and much ... May 27 and Thursday, May 28 starting at 9:00am CDT ... at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/22/2015)... 22, 2015 Pioneer Millworks, the largest ... forefront of designing with reclaimed wood, introducing their latest ... Angeles, California. Their newest offerings, Vat 35, Reclaimed ... and color to America's largest design event. , “Designers, ... each show, anxious to see and feel the variety ...
(Date:5/22/2015)... May 22, 2015 Following yesterday’s announcement ... agreement with US-based health brand Nature’s Way, Marc St-Onge ... Retention of Ascenta Skin is an integral part of ... about this opportunity to further develop Ascenta Skin into ... Ascenta Skin is a breakthrough, anti-aging skincare supplement featuring ...
(Date:5/22/2015)... DC (PRWEB) May 22, 2015 Family, ... University Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. Leffall, ... , The luncheon began after Grand Rounds in the ... Leffall, waited anxiously outside the auditorium, trying to keep ... him, but if he sees me, he’ll know something ...
(Date:5/22/2015)... 22, 2015 Power Systems is proud to ... 2015 race season. Drobeck is in his second year of ... firefighter with the Missoula Fire Department in Missoula, MT. He ... in 2014. During his career, he has had 15 1st ... recorded top 10 finishes in all seven of his 2014 ...
Breaking Medicine News(10 mins):Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2
... Levels of anxiety sensitivity may be important in ... and atrial fibrillation (AF), Montreal Heart Institute ... co-hosted by the Heart and Stroke Foundation and ... researcher and lead author Nancy Frasure-Smith, PhD explained ...
... a surgical procedure using a cutting-edge super glue pioneered ... recovery of heart patients recovering from open-chest surgery, Dr. ... co-hosted by the Heart and Stroke Foundation and the ... being used to enhance the closure of the breastbone ...
... FRIDAY, Oct. 22 (HealthDay News) -- An increasingly stubborn strain ... bacterial infection acquired in hospitals, has been identified in Ohio, ... Infectious Diseases Society of America. The strain, ST239 MRSA, ... days, the study found. It,s the first time that ...
... - A Heart and Stroke Foundation researcher has discovered ... the diagnosis and treatment of pulmonary hypertension, a devastating, ... heart. , "We have discovered an early warning system ... the Canadian Cardiovascular Congress 2010, co-hosted by the Heart ...
... Goodwin HealthDay Reporter , FRIDAY, Oct. 22 (HealthDay ... more than one-third of a monkey colony at a U.S. ... a human scientist, researchers report. Although it,s an unusual ... monitoring, the researchers stress there is no cause for alarm ...
... Oct. 22 (HealthDay News) -- You might have seen J.R. Martinez on ... vet with severe burns across much of his body who led his ... Martinez, 27, earned the right to play that role the hard way, ... first Iraq deployment as a real-life Army soldier, his Humvee hit ...
Cached Medicine News:Health News:Study suggests sensitivity to bodily symptoms of anxiety may make a difference in treatment 2Health News:Study suggests sensitivity to bodily symptoms of anxiety may make a difference in treatment 3Health News:Kryptonite superglue improving the quality of life in heart patients recovering from surgery 2Health News:MRSA Strain With Outbreak Potential Among Reports at Disease Conference 2Health News:MRSA Strain With Outbreak Potential Among Reports at Disease Conference 3Health News:Quebec City researchers pave the way for novel treatment of pulmonary hypertension 2Health News:New Virus 'Jumps' From Monkey to Scientist, Causing Serious Illness 2Health News:New Virus 'Jumps' From Monkey to Scientist, Causing Serious Illness 3Health News:New Virus 'Jumps' From Monkey to Scientist, Causing Serious Illness 4Health News:Iraq War Vet, Daytime TV Star Turns Scars Into Inspiration 2Health News:Iraq War Vet, Daytime TV Star Turns Scars Into Inspiration 3
Curved shafts with serrated 1.5 mm upper and 2 mm lower jaws. Serrated cross action handle with slide lock and polished finish. Most popular size or model....
Folding forceps used for L161U. Manufactured in titanium....
Titanium. Thin jaws provide secure grasp of the folded lens for insertion into the eye. Reverse action forceps with angled shaft....
2.5 mm cups angled 50 degrees, 10 mm from angle to tip. Serrated handle with polished finish....
Medicine Products: